Package Insert (PI) Table

Please note the following when using Package Inserts from this web site:

The drug labels and other drug-specific information on this website represent the most recent drug listing information that companies have provided to, or which is obtainable by, the Division of AIDS, NIAID, NIH (“DAIDS”), and are made available here in support of DAIDS-funded and/or -sponsored clinical trials, both domestic and international.   The drug labeling, and other information is as obtainable by DAIDS and its content has neither been altered nor verified by DAIDS; as such, this content may not be Section 508 compliant.  If in the use of adaptive equipment, you encounter problems accessing the content, DAIDS will assist access through equivalent facilitation.  Please e-mail DAIDSRSCwebsitesupport@tech-res.com for assistance.

Drugs

Drug Name Sort descending Drug Company PI Date Risk List Available?
Abacavir Sulfate/Dolutegravir/Lamivudine (Triumeq) GlaxoSmithKline October 2022
Abacavir/Lamivudine (Epzicom) GlaxoSmithKline December 2022
Bedaquiline (Sirturo) Janssen September 2021
Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy) Gilead Sciences October 2022
Clofazimine (Lamprene) Novartis January 2019
Darunavir/Cobicistat (Prezcobix) Janssen October 2022
Dolutegravir (Tivicay) ViiV Healthcare October 2022 YES
Doravirine (Pifeltro) Merck June 2022
Efavirenz Aurobindo Pharma Limited April 2022
Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (Atripla) Gilead Sciences October 2019 YES
Efavirenz/Emtricitabine/Tenofovir disoproxil fumarate (Teevir) Mylan Pharmaceuticals September 2014
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (Genvoya) Gilead Sciences January 2022
Emtricitabine/Tenofovir Alafenamide (Descovy) Gilead Sciences January 2022
Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) Gilead Sciences June 2020 YES
Estradiol Epic Pharma LLC November 2021
Ethambutol Macleods Pharmaceuticals Limited March 2021
Intralipid Fresenius Kabi Limited April 2016
Isoniazid Sandoz Inc. October 2018
Isoniazid Macleods Pharmaceuticals Ltd August 2015
Letermovir (Prevymis) Merck June 2022